Preoperatively determining renal perfusion and visualizing renal arteries and any abnormalities in potential living kidney donors using non-contrast-enhanced magnetic resonance imaging techniques at 1.5 Tesla

🔓doi.org/10.1093/ckj/sf…

Dapagliflozin treatment of patients with CKD without diabetes across different albuminuria levels

🔓doi.org/10.1093/ckj/sf…

👉Dapagliflozin demonstrated similar kidney protection, cardiorenal & all-cause mortality risk across UACR levels

Primary #hyperoxaluria in adults and children: a nationwide cohort highlight a persistent diagnostic delay

⁦CKJ⁩ #OpenAccess academic.oup.com/ckj/advance-ar…

The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients

🔓doi.org/10.1093/ckj/sf…

👉Lowering of PTH with etelcalcetide did not result in statistically significant changes in T50

New aspects in #cardiorenal syndrome and HFpEF ca. 2022 from CKJ Maria Jose Soler #Nephpearls

👉🏼 academic.oup.com/ckj/article/15…

A female patient with #Dent_disease due to skewed X-chromosome inactivation

⁦CKJ⁩ #OpenAccess

academic.oup.com/ckj/advance-ar…

CKJ Are we ready for an adipocentric approach in people living with T2D and CKD? Dysfunctional Adipose Tissue Approach #DATA #CKM
#endopower & #nephropower 🇪🇸 Sociedad SEEN SED Diabetes S.E.N. Nefrología SEMERGEN | #YoPrefieroMFyC EASD Int. Diabetes Fed. @ERAKidney doi.org/10.1093/ckj/sf…

We are delighted with the strong links built with YNP of ERA 🤝
Read about the history & initiatives of YNP doi.org/10.1093/ckj/sf…

YNPs collaborate on the In Context section🌟This month’s article is on Denosumab-induced hypocalcemia in dialysis patients doi.org/10.1093/ckj/sf…

1/ An editorial on our 10-year anniversary has been published by CKJ! Orsolya Cs. Amaryllis Van Craenenbroeck Martin de Borst Dr Dr Kate Stevens💙 Ana Carina Ferreira

ERA - European Renal Association

🧵 by Safak Mirioglu.

doi.org/10.1093/ckj/sf…

Association between diabetic status & risk of all-cause & cause-specific mortality on dialysis following first kidney allograft loss

doi.org/10.1093/ckj/sf…

There is a significant survival disadvantage with the excess mortality risk attributed to infection & dialysis withdrawal

#Lumasiran treatment in pediatric patients with #PH1 : real-world data within a compassionate use program in Italy |

⁦CKJ⁩ | #OpenAccess academic.oup.com/ckj/advance-ar…

Comparison of β-blocker agents & mortality in maintenance hemodialysis patients

🔓doi.org/10.1093/ckj/sf…

➡️Among patients on maintenance HD who were newly prescribed β-blocker medications, atenolol was associated with the lowest mortality risk compared to alternative agents

Maintained renin–angiotensin–aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multi-country cohort study

🔓doi.org/10.1093/ckj/sf…

🤰Women with CKD-Pre gestational counselling

👇Risk assessment for adverse pregnancy outcomes and counselling

CKJ

academic.oup.com/ckj/advance-ar…

The latest 'In Context' by Dr. Lloret, HanneSkouJoergensen and Pieter Evenepoel on denosumab in patients treated with dialysis!

CKJ ERA - European Renal Association

doi.org/10.1093/ckj/sf…